"Rheumatology News" Reports: Thalidomide
Proposed to Shut Off Scleroderma, Candidates Sought
"Rheumatology News," May 2005 • Volume
4 • Number 5
NEW YORK — New revelations about the complex
cellular processes underlying scleroderma suggest that
manipulating the immune system with thalidomide may
offer a new means of targeting the disease, Stephen
J. Oliver, M.D., said at a rheumatology meeting sponsored
by New York University.
(May require free registration to "Rheumatology
News.")
Read entire story.
|
